Clusterin in Alzheimer's disease: An amyloidogenic inhibitor of amyloid formation?-Reference-Cited by-同舟云学术

Clusterin in Alzheimer's disease: An amyloidogenic inhibitor of amyloid formation?

Published:2022-07 Issue:7 Volume:1868 Page:166384
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Spatharas Panagiotis M.,Nasi Georgia I.,Tsiolaki Paraskevi L.,Theodoropoulou Marilena K.,Papandreou Nikos C.,Hoenger Andreas,Trougakos Ioannis P.,Iconomidou Vassiliki A.

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference85 articles.

1. Amyloidosis: a brief history;Kyle;Amyloid,2011

2. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee;Benson;Amyloid,2020

3. Modulation of amyloid states by molecular chaperones;Wentink;Cold Spring Harb. Perspect. Biol.,2019

5. Crystallin proteins and amyloid fibrils;Ecroyd;Cell. Mol. Life Sci.,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clusterin attenuates blood–brain barrier damage and cognitive impairment by inhibiting astrocyte aging in mice with sepsis-associated encephalopathy;NeuroReport;2024-07-05

2. Brain and plasmatic CLUSTERIN are translational markers of Alzheimer's disease;Brain Pathology;2024-06-22

3. Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases;Cell Biochemistry and Function;2024-04

4. Multiomics Approach Reveals Serum Biomarker Candidates for Congenital Zika Syndrome;Journal of Proteome Research;2024-02-23

5. Complement-mediated synapse loss in Alzheimer’s disease: mechanisms and involvement of risk factors;Trends in Neurosciences;2023-12